William Balcom, MD
Orthopaedic Surgery · Worcester, MANPI 1639159841
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.8%), royalties or licence payments and speaking fees — rather than concentrated in one kind of arrangement. Exactech, Inc. accounts for 85.1% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $21,972 and has fallen 85.8% since, to $3,121 in 2023.
Across 19 payments — averaging $1363.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exactech, Inc.$22K
- Encore Medical, LP$4K
Across 26 payments — averaging $761.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Exactech, Inc.$20K
What the payments were for
- Royalty or licence$3,85215%
- Consulting fees$15,50060%
- Speaking & faculty fees$2,94811%
- Travel & lodging$2,76911%
- Food & beverage$8383%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exactech, Inc. | 13 | $22,042 |
| Encore Medical, LP | 6 | $3,864 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTETRAK$20,606
- DJO SURGICAL$9,480
- NOVATION HIP$1,194
How this compares
$25,906 in reported general payments places this provider in the 80th percentile of 542 orthopaedic surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minocycline Hcl | 11 | $322 |
| Oxycodone Hcl | 41 | $175 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 26 | $121 |
| Tramadol Hcl | 29 | $113 |
| Ibuprofen | 14 | $86 |
| Amoxicillin | 73 | $78 |
| Clindamycin Hcl | 15 | $13 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Worcester
- Paul TornettaBoston$16.3M
- Thomas ThornhillBoston$12M
- Stephen MurphyRoxbury Crossing$8M
- Andrew FreibergBoston$5.9M
- Jon WarnerBoston$5.4M
- Wolfgang FitzBoston$3.7M
- Brian KwonWaltham$1.9M
- Simon ChaoNorth Easton$1.6M
- Scott SigmanNorth Chelmsford$1.4M
- Michael LangworthyNorth Dartmouth$715K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.